PROGENICS PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN COM, CUSIP 74318710 .
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROGENICS PHARMACEUTICALS IN COM, CUSIP 74318710 .